Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05111743 |
|---|---|
| Brief Title: | Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (Komodo Health) |
| First Submitted : | October 22, 2021 |
| First Submitted that Met QC Criteria : | October 26, 2021 |
| First Posted : | November 8, 2021 |
| Last Update Submitted that Met QC Criteria : | December 15, 2021 |
| Last Update Posted : | December 21, 2021 |